Betmiga is a brand name for the medication Mirabegron. It is a prescription drug used to treat overactive bladder (OAB) symptoms such as frequent urination, urgent need to urinate, and urinary incontinence (involuntary loss of urine).
Unlike older medications for OAB, such as anticholinergics, which work by relaxing the bladder muscle, mirabegron works by activating beta-3 adrenergic receptors in the bladder, which relaxes the bladder muscle and increases bladder capacity. This helps reduce the frequency of urination and the sudden urge to urinate.
Betmiga is usually taken orally in the form of a tablet, typically once daily. It’s important to follow the dosage instructions provided by a healthcare professional. Common side effects of Betmiga may include increased blood pressure, headache, urinary tract infection, and constipation. As with any medication, it’s important to discuss potential risks and benefits with a doctor before starting treatment.
Betmiga is generally prescribed when other treatments for overactive bladder, such as behavioral therapies or anticholinergic medications, have not been effective or are not suitable due to side effects. It can be an effective option for managing the symptoms of OAB and improving quality of life for those affected by this condition.
